1996
DOI: 10.1093/nar/24.12.2252
|View full text |Cite
|
Sign up to set email alerts
|

Transactivation by the Thyroid Hormone Receptor Is Dependent on the Spacer Sequence in Hormone Response Elements Containing Directly Repeated Half-Sites

Abstract: The thyroid hormone receptor (TR) regulates the transcription of its target genes by interacting with specific hormone response elements consisting usually of directly repeated half-sites with the consensus sequence AGGTCA. To investigate the role of the spacer sequences separating the half-sites, heterodimers formed by TRalpha and the retinoid-X receptor (RXR) were used in a PCR based selection and amplification assay. The TRalpha/RXR heterodimer selected for elements with directly repeated half-sites having … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 70 publications
0
20
0
Order By: Relevance
“…Indeed, hepatocytes transfected with a PBREM construct showed only 2-fold activation after PCN treatment (Xie et al, 2000b;Smirlis et al, 2001); hepatic CYP2B10 was induced 37-fold by PB but only 7-fold by PCN (Pellinen et al, 1994); CYP2B10 mRNA induction was not affected either by thyroid hormone or by retinoic acid in mouse hepatocytes ); T3 does not seem to affect PBREM or its associated factors in rats (Ganem et al, 1999). The identity of 5Ј-flanking nucleotides in DR4 motifs is important for TR-mediated activation (Harbers et al, 1996;Zhang and Lazar, 2000) and this property may explain the discrepancy between the strong binding and inefficient function by TR␣ on PBREM. Although TR isoforms are expressed in liver (Zhang and Lazar, 2000), and TR can inhibit CAR LBD, the levels of TR relative to CAR may be too low for significant suppression via competition for NR coregulators.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Indeed, hepatocytes transfected with a PBREM construct showed only 2-fold activation after PCN treatment (Xie et al, 2000b;Smirlis et al, 2001); hepatic CYP2B10 was induced 37-fold by PB but only 7-fold by PCN (Pellinen et al, 1994); CYP2B10 mRNA induction was not affected either by thyroid hormone or by retinoic acid in mouse hepatocytes ); T3 does not seem to affect PBREM or its associated factors in rats (Ganem et al, 1999). The identity of 5Ј-flanking nucleotides in DR4 motifs is important for TR-mediated activation (Harbers et al, 1996;Zhang and Lazar, 2000) and this property may explain the discrepancy between the strong binding and inefficient function by TR␣ on PBREM. Although TR isoforms are expressed in liver (Zhang and Lazar, 2000), and TR can inhibit CAR LBD, the levels of TR relative to CAR may be too low for significant suppression via competition for NR coregulators.…”
Section: Discussionmentioning
confidence: 98%
“…The sources of expression vectors for mRAR␣ and hRAR␣ (Zelent et al, 1989), cTR␣ (Harbers et al, 1996), hLXR␤ (Teboul et al, 1995), mCOUP-TFI (NR2F1; Cooney et al, 1993), hPPAR␣ and mPPAR␣ (NR1C1; Sher et al, 1993), hFXR (Forman et al, 1995), hCAR and mCAR Sueyoshi et al, 1999), hVDR (Quack and Carlberg, 2000) and hPXR and mPXR (Lehmann et al, 1998) have been described previously. The expression plasmid for coactivator hTIF2 (Voegel et al, 1996) was donated by Dr. Hinrich Gronemeyer (IGBMC, Illkirch, France).…”
Section: Methodsmentioning
confidence: 99%
“…Recent studies have demonstrated that RXR heterodimerization can augment T 3 -mediated gene regulation to increase TR-DNA interactions (11,19). However, the magnitude of the augmentation varies significantly, especially when different cell lines were used.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have demonstrated that RXR heterodimerization can augment T 3 -mediated gene regulation to increase TR/DNA interactions (Force et al 1994, Harbers et al 1996. However, the magnitude of the augmentation varies significantly, especially when different cell lines were used.…”
Section: Discussionmentioning
confidence: 99%